Disruptive behavior disorder includes a family of disorders such as conduct disorder, oppositional defiant disorder, along with intermittent explosive disorder. Usually, it affects the young populace aged 18 years and below. Children/teenagers enduring from the disorder are not able to regulate their behaviors and emotions, act defiant, and are conflicting with other surrounding peers, thereby facing low life quality at school, home, or both. Various DBD causes comprise neglect or child abuse, traumatic life experiences including violence and sexual abuse, along with a family history for DBDs. There are a variety of options for treating DBDs, initiated with psychological therapies. In psychological therapy, guidance and counselling is provided to either the child alone or parent, or the family together, for improving response to DBD incidence. Medication treatments are suggested either combined with psychological treatments or began when the psychological therapy proves insufficient.
Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-pdf/2390
Global Disruptive Behavior Disorder Medication Market: Dynamics
Key factors accounting for the global disruptive behavior disorder medication market growth are increasing prevalence of the disruptive behavior disorders globally, increasing parent awareness regarding the disorder, and improvements in medication and psychotic treatment. As per the 2015 study published in BMJ Open (Matthew D Burkey et al) journal, conduct disorder (CD) and oppositional defiant disorder (ODD) had a global prevalence of around 3.2% and 3.3%, respectively. The World Health Organization (WHO) in its 2016 factsheet said that, 7.4% of disability-adjusted life years (DALYs) globally are caused by disorders in the category of behavioral and mental disorders.
Global Disruptive Behavior Disorder Medication Market: Regional Insights
Based On geography, the global disruptive behavior disorder medication market is segregated into North America, Europe, Latin America, Asia Pacific, Africa and Middle East. North America is expected to dominate the global disruptive behavior disorder medication market over the forecast period. As per the 2016 statistics by Agency for Healthcare Research and Quality, 3% children in the U.S. suffer from disruptive behavior disorder, in which compared to girls increased number of boys are affected among children of age 12 years and above. The initiative by Child Mind Institute (non-profit organization based in the US) – ‘Speak Up for Kids’ is a campaign through which mental health issues awareness and necessary information is given to families, the media, educators, and policymakers. Several hospitals and medical centers including Arkansas Valley Behavioral Health System have developed dedicated resources to treat disruptive behavior disorders.
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2390
Global Disruptive Behavior Disorder Medication Market: Competitive Landscape
Major players operating in the global disruptive behavior disorder medication market include Promius Pharma LLC, Johnson and Johnson, Shire PLC, Mylan N.V., Teva Pharmaceuticals Industries Ltd., Novartis AG, GlaxoSmithKline plc, Lupin Ltd., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, and others
Global Disruptive Behavior Disorder Medication Market: Market Taxonomy
Based On Disease Type,
- Intermittent Explosive Disorder
- Conduct Disorder
- Oppositional Defiant Disorder
Based On Drug Class,
- Alpha Agonist
Based On the End User,
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Based On Geography,
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027